PROTEONA PTE. LTD.

Improving Cancer Therapeutics One Cell at a Time.

PROTEONA PTE. LTD. operates in biotech, ai, pharmaceutical based in Singapore, founded in 2017.

Profile

Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services. www.proteona.com

The company sits in the biotech, ai, pharmaceutical segment, where it competes on its core product or service.

Its base of operations is Singapore.

Its current recorded stage is Startup SG directory startup.

Recorded headcount: 1 - 10 employees.

Website: www.proteona.com